Preclinical activity of brincidofovir in peripheral T-cell and NK/T-cell lymphoma
Taken together, these results demonstrate a novel role for BCV in lymphoma therapy and suggest potential for combination with checkpoint immunotherapy.
Authors
- Bavani Kannan (ORCID: https://orcid.org/0000-0001-6140-4824)
- Elizabeth Chun Yong Lee
- Dachuan Huang (ORCID: https://orcid.org/0000-0002-7518-4081)
- Kah Suan Lim
- Lim Jq
- Soon Thye Lim (ORCID: https://orcid.org/0000-0002-0366-5505)
- Jason Yongsheng Chan (ORCID: https://orcid.org/0000-0002-4801-3703)
- Kelila Xin Ye Chai (ORCID: https://orcid.org/0000-0003-2912-6451)
- Jessica Sook-Ting Kok
- Nur Ayuni Binte Muhammad Taib
- Jing Yi Lee (ORCID: https://orcid.org/0009-0005-0650-9339)
- Tun Kiat Ko (ORCID: https://orcid.org/0009-0009-1806-7370)
- Masatoshi Hazama
- Hui Yi Tay
- Choon Kiat Ong
- Koji Fukushima
- Zhimei Li
- Boon Yee Lim
- Bin Tean Teh
Institutions
- Duke-NUS Medical School (SG)
- National Cancer Centre Singapore (SG)
Publication Details
- Journal
- BMC Medicine
- Published
- 2026-02-06
- DOI
- https://doi.org/10.1186/s12916-026-04680-8
- Primary Topic
- interferon and immune responses
- Type
- article
- Field-Weighted Citation Impact
- 0.00